Dignitana AB Publishes Q2 2023 Interim Report
15 percent revenue growth driven by improved utilization Financial highlights Q2 2023 · Net sales amounted to 21.1 MSEK (18.3), an increase of 15 percent over the same period in 2022 · Operating result amounted to -4.7 MSEK (+0.1). · Net result after financial items amounted to -4.7 MSEK (-0.2). · Earnings per share were-0.07 SEK (0.00). · Cash Balance amounted to 5.4 MSEK (7.3). · Average Daily Treatment Revenue (ADTR)* was 241 TSEK (201), an increase of 20 percent over the same period in 2022. Business highlights during the period · Dignitana announced a